215 related articles for article (PubMed ID: 22261732)
21. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ
Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801
[TBL] [Abstract][Full Text] [Related]
22. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
Steinemann D; Skawran B; Becker T; Tauscher M; Weigmann A; Wingen L; Tauscher S; Hinrichsen T; Hertz S; Flemming P; Flik J; Wiese B; Kreipe H; Lichter P; Schlegelberger B; Wilkens L
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1283-91. PubMed ID: 16979954
[TBL] [Abstract][Full Text] [Related]
23. Distinct set of chromosomal aberrations in childhood hepatocellular carcinoma is correlated to hepatitis B virus infection.
Tan L; Meier T; Kuhlmann M; Xie F; Baier C; Zhu Z; Cong WM; Wilkens L
Cancer Genet; 2016 Mar; 209(3):87-96. PubMed ID: 26837720
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization.
Uhm KO; Park YN; Lee JY; Yoon DS; Park SH
Cancer Genet Cytogenet; 2005 Feb; 157(1):37-41. PubMed ID: 15676145
[TBL] [Abstract][Full Text] [Related]
25. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization.
Marchio A; Meddeb M; Pineau P; Danglot G; Tiollais P; Bernheim A; Dejean A
Genes Chromosomes Cancer; 1997 Jan; 18(1):59-65. PubMed ID: 8993981
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of a human cholangiocarcinoma cell line.
Ma S; Hu L; Huang XH; Cao LQ; Chan KW; Wang Q; Guan XY
Oncol Rep; 2007 Nov; 18(5):1195-200. PubMed ID: 17914572
[TBL] [Abstract][Full Text] [Related]
27. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.
Qin LX; Tang ZY; Sham JS; Ma ZC; Ye SL; Zhou XD; Wu ZQ; Trent JM; Guan XY
Cancer Res; 1999 Nov; 59(22):5662-5. PubMed ID: 10582679
[TBL] [Abstract][Full Text] [Related]
28. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis.
Niketeghad F; Decker HJ; Caselmann WH; Lund P; Geissler F; Dienes HP; Schirmacher P
Br J Cancer; 2001 Sep; 85(5):697-704. PubMed ID: 11531255
[TBL] [Abstract][Full Text] [Related]
29. The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential.
Yang J; Qin LX; Ye SL; Liu YK; Li Y; Gao DM; Chen J; Tang ZY
J Cancer Res Clin Oncol; 2003 May; 129(5):303-8. PubMed ID: 12750998
[TBL] [Abstract][Full Text] [Related]
30. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
Weber RG; Pietsch T; von Schweinitz D; Lichter P
Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
[TBL] [Abstract][Full Text] [Related]
31. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
[TBL] [Abstract][Full Text] [Related]
32. Genomic alterations in distal bile duct carcinoma by comparative genomic hybridization and karyotype analysis.
Rijken AM; Hu J; Perlman EJ; Morsberger LA; Long P; Kern SE; Hruban RH; Yeo CJ; Griffin CA
Genes Chromosomes Cancer; 1999 Nov; 26(3):185-91. PubMed ID: 10502315
[TBL] [Abstract][Full Text] [Related]
33. Characterization and genetic analysis in the newly established human bile duct cancer cell lines.
Ghosh M; Koike N; Tsunoda S; Hirano T; Kaul S; Kashiwagi H; Kawamoto T; Ohkohchi N; Saijo K; Ohno T; Miwa M; Todoroki T
Int J Oncol; 2005 Feb; 26(2):449-56. PubMed ID: 15645130
[TBL] [Abstract][Full Text] [Related]
34. Infrequent amplification of JUN in hepatocellular carcinoma.
Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
[TBL] [Abstract][Full Text] [Related]
35. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction.
Yen CC; Chen YJ; Lu KH; Hsia JY; Chen JT; Hu CP; Chen PM; Liu JH; Chiou TJ; Wang WS; Yang MH; Chao TC; Lin CH
Int J Oncol; 2003 Oct; 23(4):871-81. PubMed ID: 12963965
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
Lau SH; Guan XY
Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
[TBL] [Abstract][Full Text] [Related]
37. Distinct chromosomal bias of gene expression signatures in the progression of hepatocellular carcinoma.
Midorikawa Y; Tsutsumi S; Nishimura K; Kamimura N; Kano M; Sakamoto H; Makuuchi M; Aburatani H
Cancer Res; 2004 Oct; 64(20):7263-70. PubMed ID: 15492245
[TBL] [Abstract][Full Text] [Related]
38. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung.
Petersen I; Bujard M; Petersen S; Wolf G; Goeze A; Schwendel A; Langreck H; Gellert K; Reichel M; Just K; du Manoir S; Cremer T; Dietel M; Ried T
Cancer Res; 1997 Jun; 57(12):2331-5. PubMed ID: 9192802
[TBL] [Abstract][Full Text] [Related]
39. Genotype stability and clonal evolution of hepatocellular carcinoma assessed by autopsy-based genome-wide microsatellite analysis.
Nishimura T; Nishida N; Komeda T; Fukuda Y; Nakao K
Cancer Genet Cytogenet; 2005 Sep; 161(2):164-9. PubMed ID: 16102588
[TBL] [Abstract][Full Text] [Related]
40. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
